‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers
‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers
www.theguardian.com ‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers
As regulator prepares to approve Lenacapavir in the US, campaigners are urging the manufacturer, Gilead, to make it ‘available and affordable for all who need it’

You're viewing a single thread.
All comments
48
comments
Pharma C-suite:
that doesn’t sound very profitable
I fucking wish I was kidding
77 0 Reply"But how does this expand shareholder value"
9 0 ReplyI mean, it doesn't actually end it, to have to keep taking their pill. It's a subscription model to life.
4 0 ReplyPill
You could read the article before you comment lol
14 0 ReplyYou caught me!
2 0 Reply
48
comments
Scroll to top